These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23349802)

  • 21. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS.
    López MC; Duckett NS; Baron SD; Metzger DW
    Cell Immunol; 2004; 232(1-2):75-85. PubMed ID: 15922718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
    Griffin AJ; Crane DD; Wehrly TD; Scott DP; Bosio CM
    PLoS One; 2013; 8(12):e82096. PubMed ID: 24324751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.
    Periasamy S; Singh A; Sahay B; Rahman T; Feustel PJ; Pham GH; Gosselin EJ; Sellati TJ
    J Leukoc Biol; 2011 Sep; 90(3):493-507. PubMed ID: 21724804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.
    Cole LE; Mann BJ; Shirey KA; Richard K; Yang Y; Gearhart PJ; Chesko KL; Viscardi RM; Vogel SN
    J Leukoc Biol; 2011 Oct; 90(4):787-97. PubMed ID: 21750122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
    D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
    Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
    Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.
    Forestal CA; Gil H; Monfett M; Noah CE; Platz GJ; Thanassi DG; Benach JL; Furie MB
    Microb Pathog; 2008 Jun; 44(6):512-23. PubMed ID: 18304778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
    Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
    Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid onset of ICAM-1 expression is a marker of effective macrophages activation during infection of Francisella tularensis LVS in vitro.
    Novosad J; Holicka M; Novosadova M; Krejsek J; Krcmova I
    Folia Microbiol (Praha); 2011 Mar; 56(2):149-54. PubMed ID: 21476047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
    Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ
    PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasome-Independent NLRP3 Restriction of a Protective Early Neutrophil Response to Pulmonary Tularemia.
    Periasamy S; Le HT; Duffy EB; Chin H; Harton JA
    PLoS Pathog; 2016 Dec; 12(12):e1006059. PubMed ID: 27926940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of early interactions between Francisella and the host.
    Roberts LM; Tuladhar S; Steele SP; Riebe KJ; Chen CJ; Cumming RI; Seay S; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
    Infect Immun; 2014 Jun; 82(6):2504-10. PubMed ID: 24686053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal requirements for murine resistance to infection with Francisella tularensis LVS.
    Elkins KL; Rhinehart-Jones TR; Culkin SJ; Yee D; Winegar RK
    Infect Immun; 1996 Aug; 64(8):3288-93. PubMed ID: 8757866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of NK cells in host defense against pulmonary type A Francisella tularensis infection.
    Schmitt DM; O'Dee DM; Brown MJ; Horzempa J; Russo BC; Morel PA; Nau GJ
    Microbes Infect; 2013 Mar; 15(3):201-11. PubMed ID: 23211929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.
    D'Elia RV; Laws TR; Núñez A; Taylor C; Clark GC
    Microb Pathog; 2015 Jan; 78():37-42. PubMed ID: 25284816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.